The thienopyridines in coronary artery disease

Current Cardiology Reports

Volumn 1, Issue 3, 1999, Pages 192-198

  Berger, Peter B ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTITHROMBOCYTIC AGENT; CLOPIDOGREL; DRUG DERIVATIVE; TICLOPIDINE;

CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CORONARY ARTERY DISEASE; CORONARY ARTERY THROMBOSIS; HUMAN; RANDOMIZED CONTROLLED TRIAL; REVIEW; STENT; TRANSLUMINAL CORONARY ANGIOPLASTY;

ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; ASPIRIN; CORONARY DISEASE; CORONARY THROMBOSIS; HUMANS; PLATELET AGGREGATION INHIBITORS; RANDOMIZED CONTROLLED TRIALS; STENTS; TICLOPIDINE;

EID: 0033187329     PISSN: 15233782     EISSN: 15343170     Source Type: Journal    
DOI: 10.1007/s11886-999-0022-z     Document Type: Article

References (34)

1. Antiplatelet Trialist's Collaboration. Collaborative overview of randomised trials of antiplatelet therapy - I: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. BMJ 1994, 308:81-106.
2. Helgason CM, Tortorice KL, Winkler SR, et al.: Aspirin response and failure in cerebral infarction. Stroke 1993, 24:345-350.
3. Helgason CM, Bolin KM, Hoff JA, et al.: Development of aspirin resistance in persons with previous ischemic stroke. Stroke 1994, 25:2331-2336.
4. Grotemeyer KH, Scharafinski HW, Husstedt IW: Two-year follow-up of aspirin responder and aspirin non responder. A pilot-study including 180 post-stroke patients. Thromb Res 1993, 71:397-403.
5. Buchanan MR, Brister SJ: Individual variation in the effects of ASA on platelet function: implications for the use of ASA clinically. Can J Cardiol 1995, 11: 221-227.
6. Coukell AJ, Markham A: Clopidogrel. Drugs 1997, 54:745-750.
7. Savi P, Herbert JM: ADP receptors on platelets and ADP-selective antiaggregating agents. Med Res Rev 1996, 16:159-179.
8. Mills DC, Puri R, Hu CJ, et al.: Clopidogrel inhibits the binding of ADP analogues to the receptor mediating inhibition of platelet adenylate cyclase. Arterioscler Thromb 1992, 12:430-436.
9. Yang LH, Fareed J: Vasomodulatory action of clopidogrel and ticlopidine. Thromb Res 1997, 86:479-491.
10. Puri RN, Colman RW: ADP-induced platelet activation. Crit Rev biochem molec biol 1997, 3:437-502.
11. Balsano F, Rizzon P, Violi F, et al.: Antiplatelet treatment with ticlopidine in unstable angina. A controlled multicenter clinical trial. The Studio della Ticlopidina nell'Angina Instabile Group. Circulation 1990, 82:17-26.
12. Bertrand ME, Allain H, Lablanche JM: Results of a randomized trial of ticlopidine versus placebo for prevention of acute closure and restenosis after coronary angioplasty (PTCA): the TACT study. Circulation 1990, 82:111-190.
13. White CW: Antiplatelet agents are effective in reducing the immediate complications of PTCA: Results from the ticlopidine multicenter trial. Circulation 1987, 76 (Suppl IV):IV-400.
14. Berger PB, Dzavik V, Al-Rashdan I, et al.: Does Ticlopidine Reduce Reocclusion After Successful Balloon Angioplasty of Coronary Occlusions? Insights from TOSCA [abstract]. J Am Coll Cardiol. 1999, 33:40A.
15. Morice M-C, Lefevre T, Grines CL, et al.: Antiplatelet treatment with ticlopidine and aspirin does not prevent major adverse cardias events in acute myocardial infarction patients treated with balloon angioplasty alone. Circulation 1998, 98(Suppl I):I-572A.
16. Leon MB, Baim DS, Popma JJ, et al.: A clinical trial comparing three antithrombotic-drug regimens after coronary-artery stenting. Stent Anticoagulation Restenosis Study. New Engl J Med 1998, 339:1665-1671.
17. Schomig A, Neumann FJ, Kastrati A, et al.: A randomized comparison of antiplatelet and anticoagulant therapy after the placement of coronary-artery stents. New Engl J Med 1996, 334:1084-1089.
18. Hall P, Nakamura S, Maiello L, et al.: A randomized comparison of combined ticlopidine and aspirin therapy versus aspirin therapy alone after successful intravascular ultrasound-guided stent implantation. Circulation 1996, 93:215-222.
19. Urban P, Macaya C, Rupprecht HJ, et al.: Randomized evaluation of anticoagulation versus antiplatelet therapy after coronary stent implantation in high-risk patients: the multicenter aspirin and ticlopidine trial after intracoronary stenting (MATTIS). Circulation 1998, 98:2126-2132.
20. Bertrand ME, Legrand V, Boland J, et al.: Randomized multicenter comparison of conventional anticoagulation versus antiplatelet therapy in unplanned and elective coronary stenting. The full anticoagulation versus aspirin and ticlopidine (FANTASTIC) study. Circulation 1998, 98:1597-1603.
21. Rupprecht HJ, Darius H, Borkowski U, et al.: Comparison of antiplatelet effects of aspirin, ticlopidine, or their combination after stent implantation. Circulation 1998, 97:1046-1052.
22. Wilson S, Rihal CS, Bell MR, et al.: Timing of coronary stent thrombosis in patients treated with ticlopidine and aspirin. Am J Cardiol 1999, 83:1006-1011.
23. Schomig A, Kastrati A, Shuhlen H, et al.: Risk factor analysis for stent occlusion within the first month after successful coronary stent placement. J Am Coll Cardiol 1998, 31(Suppl A):99A.
24. Steinhubl SR, Lauer MS, Mukherjee DP, et al.: The duration of pretreatment with ticlopidine prior to stenting is associated with the risk of procedure-related non-Q-wave myocardial infarctions. J Am Coll Cardiol 1998, 32:1366-1370.
25. Steinhubl SR, Bulog C, Topol EJ: Pretreatment with ticlopidine prior to stenting is associated with a substantial decrease in complications: data from the EPISTENT trial [abstract]. Circulation 1998, 98(Suppl I):I-573.
26. The EPISTENT Investigators. Randomised placebo-controlled and balloon-angioplasty-controlled trial to assess safety of coronary stenting with use of platelet glycoprotein-IIb/IIIa blockade. Evaluation of Platelet IIb/IIIa Inhibitor for Stenting. Lancet 1998, 352:87-92.
27. Steinhubl SR, Tan WA, Foody JM, et al.: Incidence and clinical course of thrombotic thrombocytopenic purpura due to ticlopidine following coronary stenting. JAMA 1999, 281:806-810.
28. Berger PB, Bell MR, Grill DE, et al.: Safety and efficacy of ticlopidine for only two weeks after successful intracoronary stent placement. Circulation. 1999, 99:248-253.
29. Boneu B, Destelle G: Platelet anti-aggregating activity and tolerance of clopidogrel in atherosclerotic patients. Thromb Haemost 1996, 76:939-943.
30. The CAPRIE Investigators: A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). Lancet 1996, 348:1329-1339.
31. Easton JD: Net benefit of clopidogrel over aspirin for the prevention of atherothrombotic events. Cerebrovasc Dis 1998, 8(suppl 4):46.
32. Gibbons RJ, Chatterjee K, Daley J, et al.: ACC/AHA/ACP-ASIM guidelines for the management of patients with chronic stable angina: executive summary and recommendations. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Patients with Chronic Stable Angina). Circulation 1999, 99:2829-2848.
33. Bachmann F, Savcic M, Hauert J, et al.: Rapid onset of inhibition of ADP-induced platelet aggregation by a loading dose of clopidogrel. Eur Heart J 1996, Suppl 263A.
34. Wang X, Oetgen M, Maida R, et al.: The effectiveness of the combination of Plavix and aspirin versus Ticlid and aspirin after coronary stent implantation. J Am Coll Cardiol 1999, 33:13A.